Mi-Hyeon You[Author] - Search Results

Year	Number of Results
2007	1
2008	1
2009	1
2010	1
2011	1
2012	1
2013	1
2015	2
2016	3
2017	1
2019	2
2020	1
2021	3
2022	1
2023	1
2024	0

1

TGFβ4 alleviates the phenotype of Charcot-Marie-Tooth disease type 1A.

Jeon H, Jang SY, Kwak G, Yi YW, You MH, Park NY, Jo JH, Yang JW, Jang HJ, Jeong SY, Moon SK, Doo HM, Nahm M, Kim D, Chang JW, Choi BO, Hong YB. Jeon H, et al. Among authors: you mh. Brain. 2023 Sep 1;146(9):3608-3615. doi: 10.1093/brain/awad147. Brain. 2023. PMID: 37143322

2

The role of Slit2 as a tumor suppressor in thyroid cancer.

Jeon MJ, Lim S, You MH, Park Y, Song DE, Sim S, Kim TY, Shong YK, Kim WB, Kim WG. Jeon MJ, et al. Among authors: you mh. Mol Cell Endocrinol. 2019 Mar 1;483:87-96. doi: 10.1016/j.mce.2019.01.010. Epub 2019 Jan 12. Mol Cell Endocrinol. 2019. PMID: 30648543

3

Effects of dabrafenib and erlotinib combination treatment on anaplastic thyroid carcinoma.

Choi YS, Kwon H, You MH, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim WG. Choi YS, et al. Among authors: you mh. Endocr Relat Cancer. 2022 May 9;29(6):307-319. doi: 10.1530/ERC-22-0022. Endocr Relat Cancer. 2022. PMID: 35343921

4

Nasopharyngeal oncocytoma in a cat.

You MH, Kim YB, Woo GH, Kim JY, Yoon J, Youn HY, Kim DY. You MH, et al. J Vet Diagn Invest. 2011 Mar;23(2):391-4. doi: 10.1177/104063871102300237. J Vet Diagn Invest. 2011. PMID: 21398472

5

Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression.

You MH, Jeon MJ, Kim SR, Lee WK, Cheng SY, Jang G, Kim TY, Kim WB, Shong YK, Kim WG. You MH, et al. Sci Rep. 2021 Jan 21;11(1):2054. doi: 10.1038/s41598-021-81469-0. Sci Rep. 2021. PMID: 33479369 Free PMC article.

6

High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.

Jeon MJ, You MH, Han JM, Sim S, Yoo HJ, Lee WK, Kim TY, Song DE, Shong YK, Kim WG, Kim WB. Jeon MJ, et al. Among authors: you mh. Thyroid. 2020 Nov;30(11):1625-1638. doi: 10.1089/thy.2020.0105. Epub 2020 Jun 26. Thyroid. 2020. PMID: 32438862 Free PMC article.

7

SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer.

Jin M, Lee WK, You MH, Jang A, Cheng SY, Kim WG, Jeon MJ, Lee YM. Jin M, et al. Among authors: you mh. Endocr Connect. 2021 Jun 16;10(6):630-636. doi: 10.1530/EC-21-0135. Endocr Connect. 2021. PMID: 34010151 Free PMC article.

8

Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers.

You MH, Lee WK, Jin M, Song DE, Cheng SY, Kim TY, Kim WB, Jeon MJ, Kim WG. You MH, et al. Cells. 2021 Nov 3;10(11):2994. doi: 10.3390/cells10112994. Cells. 2021. PMID: 34831219 Free PMC article.

9

Expression of NF2 Modulates the Progression of BRAF^V600E Mutated Thyroid Cancer Cells.

You MH, Jeon MJ, Kim TY, Kim WB, Shong YK, Kim WG. You MH, et al. Endocrinol Metab (Seoul). 2019 Jun;34(2):203-212. doi: 10.3803/EnM.2019.34.2.203. Endocrinol Metab (Seoul). 2019. PMID: 31257748 Free PMC article.

10

Death-associated protein kinase 1 phosphorylates NDRG2 and induces neuronal cell death.

You MH, Kim BM, Chen CH, Begley MJ, Cantley LC, Lee TH. You MH, et al. Cell Death Differ. 2017 Feb;24(2):238-250. doi: 10.1038/cdd.2016.114. Epub 2016 Nov 4. Cell Death Differ. 2017. PMID: 28141794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year